Evidence map›Paper›PMID 29152677›Full record

ArticleCurrent psychiatry reports2017

ADHD and Anxiety: Clinical Significance and Treatment Implications.

Frederick W Reimherr, Barrie K Marchant, Thomas E Gift, Tammy A Steans

Abstract read
PubMed Publisher
In one paragraph

Article in Current psychiatry reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Frederick W ReimherrPsychiatric & Behavioral Solutions, 1522 South 1100 East, Salt Lake City, UT, 84105, USA. fred.reimherr@hsc.utah.edu.
Barrie K MarchantPsychiatric & Behavioral Solutions, 1522 South 1100 East, Salt Lake City, UT, 84105, USA.
Thomas E GiftUniversity of Rochester School of Medicine, Rochester, NY, USA.
Tammy A SteansPsychiatric & Behavioral Solutions, 1522 South 1100 East, Salt Lake City, UT, 84105, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In comparison to the DSM formulation of ADHD, we have proposed that ADHD in adults should be divided into Inattentive and Emotional Dysregulation Presentations. Under both systems, there is potential overlap with generalized anxiety disorder (GAD). We compared data from four distinct populations: ADHD clinical trials, GAD clinical trials, an ADHD clinic, and a forensic clinic. Approximately 25% of patients in each population had comorbid ADHD and anxiety. Comorbid subjects reported more childhood ADHD symptoms and higher scores on ADHD scales and were more likely to fit criteria for ADHD Emotional Dysregulation Presentation or DSM-IV combined type. Comorbid subjects did not drop out at a higher rate and showed significant drug-placebo differences on ADHD symptoms, including Emotional Dysregulation. Conversely, although symptoms of anxiety decreased, there was no drug-placebo difference in improvement.

Indexed as

AdultAnxietyAnxiety DisordersAttentionAttention Deficit Disorder with HyperactivityClinical Trials as TopicComorbidityDiagnostic and Statistical Manual of Mental DisordersEmotionsFemaleHumansMaleADHDAnxietyEmotional dysregulationGADTreatment responseWRAADDS

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.